Triglav Skladi’s DexCom DXCM Stock Holding History

Triglav Skladi’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.16M	Hold	18,500	–	–	0.08%	115
2025 Q4	$1.23M	Hold	18,500	–	–	0.08%	122
2025 Q3	$1.24M	Hold	18,500	–	–	0.08%	104
2025 Q2	$1.61M	Hold	18,500	–	–	0.12%	89
2025 Q1	$1.26M	Hold	18,500	–	–	0.11%	93
2024 Q4	$1.44M	Buy	+18,500	New	+$1.37M	0.11%	92

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Triglav Skladi's DXCM Position: Q1 2026 in Review

Triglav Skladi held its DexCom (DXCM) position steady in Q1 2026 at 18,500 shares worth $1.16M. The position accounts for 0.08% of the portfolio, ranked #115.

Triglav Skladi first reported a position in DXCM in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.61M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Triglav Skladi held 18,500 shares of DexCom worth $1.16M as of Q1 2026.
Triglav Skladi left its DexCom share count unchanged in Q1 2026.
DexCom made up 0.08% of Triglav Skladi's portfolio in Q1 2026, its #115 holding.
Triglav Skladi first reported a position in DexCom in Q4 2024 and has held it in 6 quarters since.
Triglav Skladi's DexCom position peaked at $1.61M in Q2 2025.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Triglav Skladi's 13F filing for Q1 2026, filed 4 May 2026.